Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Applied Workflows with Angiotensin 1/2 (2-7) Peptide in RAS
2026-05-20
Angiotensin 1/2 (2-7) peptide stands out for its unmatched purity, robust solubility, and specificity in modeling renin-angiotensin signaling. This article dissects practical workflows, advanced applications, and troubleshooting strategies for maximizing experimental insight in cardiovascular and viral pathogenesis studies.
-
Nystatin (Fungicidin): Reliable Antifungal Solutions for Res
2026-05-20
This article addresses key laboratory challenges encountered in antifungal research and cell-based assays, focusing on the practical deployment of Nystatin (Fungicidin), SKU B1993. Drawing on quantitative benchmarks and evidence-backed workflows, it demonstrates how this APExBIO reagent supports reproducible, sensitive, and safe experimental outcomes for biomedical researchers.
-
Brain-to-Spinal Circuits Regulating Mechanical Allodynia Lat
2026-05-19
Huo et al. (2023) reveal a descending neural pathway—from lateral parabrachial Oprm1+ neurons via hypothalamic dynorphinergic cells to the spinal cord—that critically regulates the laterality and persistence of mechanical allodynia in mice. This work advances understanding of how brain circuits modulate pain hypersensitivity and offers new frameworks for dissecting opioid receptor function in pain research.
-
WM-8014: KAT6A Inhibitor for Precision Cancer Biology Resear
2026-05-19
WM-8014 enables selective, reversible inhibition of KAT6A/B, transforming workflows in oncogene-induced senescence studies. Its robust, non-cytotoxic profile and nanomolar potency set a new standard for dissecting cell cycle arrest and epigenetic dependencies.
-
Applied Workflows with Angiotensin 1/2 (2-7) Peptide in Rese
2026-05-18
Angiotensin 1/2 (2-7) peptide enables precise modeling of the renin-angiotensin system, driving advances in blood pressure regulation and viral pathogenesis research. This article delivers actionable workflow enhancements, troubleshooting strategies, and protocol parameters that maximize experimental reproducibility and translational value.
-
Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding
2026-05-18
This study reveals that naturally occurring angiotensin peptides, including N-terminally truncated forms such as Angiotensin III, significantly enhance SARS-CoV-2 spike protein binding to the AXL receptor. These findings expand the understanding of peptide-mediated modulation of viral entry and suggest new avenues for investigating the intersection between cardiovascular peptide signaling and viral infection.
-
Sodium Ascorbate: Mechanisms and Benchmarks in Cancer Resear
2026-05-17
Sodium Ascorbate, a mineral salt of ascorbic acid, is a highly bioavailable agent that induces intracellular ROS and necrotic tumor cell death, particularly in glioblastoma models. Evidence shows significant inhibition of tumor proliferation without hematological toxicity. This dossier outlines precise parameters, mechanistic details, and practical workflow guidance for translational oncology.
-
AM251: Precision Protocols for CB1 Receptor Antagonist Resea
2026-05-16
AM251 is a nanomolar-potency CB1 receptor antagonist that enables targeted dissection of endocannabinoid pathways, metabolic regulation, and cell signaling. This article delivers actionable workflows and troubleshooting strategies, bridging advanced cannabinoid receptor research with translational assay development.
-
ω-Agatoxin IVA TFA: Precision Tools for Synaptic Research
2026-05-15
ω-Agatoxin IVA TFA from APExBIO enables precise dissection of P/Q-type calcium channel contributions in neuronal signaling and epilepsy models. This article delivers practical protocols, troubleshooting strategies, and comparative insights to help you leverage this reagent for advanced synaptic and neuroprotection studies.
-
Dronedarone (Multaq): Applied Workflows in Atrial Fibrillati
2026-05-15
Harness the multi-ion channel activity and CYP inhibition profile of Dronedarone (Multaq) to advance atrial fibrillation and flutter research. This guide delivers stepwise protocol enhancements, troubleshooting strategies, and integrates benchmark evidence for reproducible experimental success.
-
Technical Use of Angiotensin I/II (1-5) in RAS Assays
2026-05-14
Angiotensin I/II (1-5) is a defined Asp-Arg-Val-Tyr-Ile peptide fragment used to model the renin-angiotensin system (RAS) in hypertension and renal studies where precise control of blood pressure regulation and aldosterone stimulation is required. It is not suitable for workflows outside cardiovascular and renal physiology due to its solubility profile and defined mechanistic action.
-
Filipin III: Advancing Cholesterol Detection for Translation
2026-05-14
This thought-leadership article explores the strategic and mechanistic value of Filipin III—a polyene macrolide antibiotic—for cholesterol detection in membranes, especially in the context of metabolic liver diseases. By integrating recent insights from MASLD (metabolic dysfunction-associated steatotic liver disease) research, competitive methodological perspectives, and translational workflow guidance, the article offers actionable advice for researchers seeking to bridge membrane biology with real-world therapeutic innovation. It uniquely positions APExBIO’s Filipin III as an indispensable reagent, contextualizing its use with protocol parameters, literature-based evidence, and a forward-looking outlook on the evolving landscape of cholesterol microdomain research.
-
Thymosin-β4 Promotes Angiogenesis in CLI via Notch/NF-κB Pat
2026-05-13
This study demonstrates that thymosin-β4 enhances angiogenesis and cell viability in a mouse model of critical limb ischemia (CLI) by modulating the Notch and NF-κB signaling pathways. The findings provide mechanistic insights for developing novel therapeutic strategies for CLI and validate the use of colorimetric cell viability assays, such as those using MTT, for evaluating cellular responses.
-
Phenacetin in Scientific Research: Applied Protocols & Troub
2026-05-13
Phenacetin (N-(4-ethoxyphenyl)acetamide) is a gold-standard probe for absorption and metabolism workflows, leveraging its unique solubility and stability profile. This article provides actionable protocols, advanced troubleshooting, and direct links to cutting-edge applications in organoid models and pharmacokinetic studies.
-
ARCA Cy5 EGFP mRNA (5-moUTP): Precision for mRNA Delivery As
2026-05-12
ARCA Cy5 EGFP mRNA (5-moUTP) sets a new benchmark for quantifying mRNA delivery, localization, and translation efficiency in mammalian cells. Its dual fluorescent labeling and 5-methoxyuridine modification enable seamless workflow integration, minimize immune activation, and deliver actionable insights for mRNA system development.